Sanner Ventures

Sanner Ventures GmbH is a single-family office based in Bensheim, Germany, that focuses on seed and early-stage investments. The firm specializes in investing in technological companies within the health and well-being sectors. Established in 1894, Sanner Ventures aims to support innovative ventures that contribute to advancements in health-related technologies.

Jürgen Sanner

Managing Director

3 past transactions

Fertilly

Seed Round in 2021
Developer of a digital health platform intended to assist women, men, and couples throughout their fertility journeys. The company's platform helps patients to find the right fertility clinic and also accompanies the patients from the first consultation to the birth of their dream child, enabling patients to have the desire for children, artificial insemination, and social freezing during pregnancy.

Baze

Venture Round in 2018
Baze Labs, Inc. operates an online subscription platform and mobile application for ordering personalized supplements. The customers can do a blood test at home by using a procedure kit. The procedure kit is created in such a way that based on the blood values, algorithms calculate nutrient deficiencies and recommend appropriate supplements. The customers can access the personal values and also an individual recommendation for additional products. These are delivered to home in the right dosage. Baze Labs, Inc. was incorporated in 2017 and is based in Watertown, Massachusetts.

Amiko

Corporate Round in 2017
Amiko is a healthcare technology company focused on developing advanced medication sensor technologies and AI-driven digital health solutions. Founded in 2014, the company operates from its headquarters in London and has research and development facilities in Milan. Amiko's flagship product, Respiro, is a connected platform designed to enhance respiratory care through smart devices, applications, and analytics, thereby improving health outcomes and reducing healthcare costs. The company also offers Quantified Medicine, a platform that manages chronic treatments by analyzing medication usage data across various drug delivery devices, including inhalers and insulin pens. Amiko serves a diverse clientele, including commercial, institutional, and individual customers across several European countries. Through its innovative solutions, Amiko aims to empower patients, caregivers, and healthcare professionals in the pursuit of improved health management and disease outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.